Subject: RXMD CEO Discusses Record Revenue and Acquisition Progress in New Interview

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
RXMD CEO Discusses Record Revenue and Acquisition Progress in New Interview
Hot Stock to WatchHot Stock to Watch

Company: Progressive Care Inc. (OTCQB: RXMD)


Price: 0.062

Change (%): - 0.008 (11.43)

Volume: 1,870,685
RXMD Chart

S. Parikh Mars, CEO of Progressive Care Inc., Discusses Record January Revenues, Provides an Acquisition Update and a 2019 Outlook in a New Audio Interview with

AUSTIN, Texas, Feb. 25, 2019 (GLOBE NEWSWIRE) —, Inc. and Progressive Care Inc. (OTC.QB: RXMD), a personalized healthcare services and technology company, announced today that the Company is featured in a new audio interview at, Inc.

The interview featuring RXMD’s CEO, current news and industry trends can be heard at

S. Parikh Mars, CEO of Progressive Care Inc. called in to, Inc. to go over the drivers behind the recently announced best January in Company history in terms of revenue and prescriptions filled, the progress with the ongoing acquisition of the Florida based pharmacy with 2 operating locations, the extensive media coverage garnered in the Company’s fight against the opioid crisis, provide an outlook for 2019 and much more.

Continue Reading

Progressive Care Inc. Garners Coverage in CBS Miami for Creating Custom-Made Lotion Alternatives to Opioids

MIAMI, Feb. 25, 2019 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered media coverage in CBS Miami for creating custom-made lotions as an alternative to opioids.

“It is a true honor to be recognized in our local community by CBS Miami for the work that Pharmco RX and Progressive Care is doing to address the opioid crisis,” said S. Parikh Mars, CEO of Progressive Care Inc. “Progressive Care aims to provide patients with custom-made compounds to suit each patient’s needs. These compounds are helping to lower our patients’ dependency on opioids and fight the epidemic.”

In a segment titled Patients Find Alternative to Opioids in Custom-Made Lotions, published February 20, 2019 in CBS Miami, the reporter interviewed Pharmco RX patient Constance Scott regarding her experience using the Progressive Care custom-made lotions and Shital Mars regarding how the pharmacy helps to address their patients’ needs with treatments to restore the functionality that they deserve.

Continue Reading

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks